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Abstract
Distal gut bacteria play a pivotal role in the digestion of dietary polysaccharides by producing a large number of
carbohydrate-active enzymes (CAZymes) that the host otherwise does not produce. We report here the design of a custom
microarray that we used to spot non-redundant DNA probes for more than 6,500 genes encoding glycoside hydrolases and
lyases selected from 174 reference genomes from distal gut bacteria. The custom microarray was tested and validated by
the hybridization of bacterial DNA extracted from the stool samples of lean, obese and anorexic individuals. Our results
suggest that a microarray-based study can detect genes from low-abundance bacteria better than metagenomic-based
studies. A striking example was the finding that a gene encoding a GH6-family cellulase was present in all subjects
examined, whereas metagenomic studies have consistently failed to detect this gene in both human and animal gut
microbiomes. In addition, an examination of eight stool samples allowed the identification of a corresponding CAZome core
containing 46 families of glycoside hydrolases and polysaccharide lyases, which suggests the functional stability of the gut
microbiota despite large taxonomical variations between individuals.
Citation: El Kaoutari A, Armougom F, Leroy Q, Vialettes B, Million M, et al. (2013) Development and Validation of a Microarray for the Investigation of the
CAZymes Encoded by the Human Gut Microbiome. PLoS ONE 8(12): e84033. doi:10.1371/journal.pone.0084033
Editor: Mario F. Feldman, University of Alberta, Canada
Received July 18, 2013; Accepted November 11, 2013; Published December 31, 2013
Copyright:  2013 El Kaoutari et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work has been supported by the Mediterranean Infection Foundation (http://www.mediterranee-infection.com). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bernard.henrissat@afmb.univ-mrs.fr
. These authors contributed equally to this work.
¤ Current address: Institut Curie, Centre de Recherche, Plateforme NGS, Paris, France
Introduction
Following the early 16S rRNA survey conducted by Eckburg
and colleagues [1] and the advent of modern sequencing
technologies [2,3], the organismal diversity of the human gut
microbiota is now being widely studied [4,5]. Although important
inter-individual variability at the species level exists [1], the human
gut microbiota commonly hosts bacterial species from the
Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria
phyla and includes a few members belonging to the Archaea
and Eukaryota kingdoms [6] as well as viruses [7,8]. Shifts in the
composition and function of the human gut microbiota have been
suggested as possible break points for the health state and are thus
associated with diseases, including obesity [9,10,11,12,13], diabe-
tes, non-alcoholic fatty liver disease [11,14,15], colonic cancer [16]
and allergy [17].
An important role of the human gut microbiome in health and
nutrition is to metabolize dietary plant and animal glycans as well
as the carbohydrates of the host mucus [18]. The plant-derived
complex carbohydrates are provided by vegetables, cereals, fruits
and leguminous seeds, whereas the animal-derived dietary glycans
are provided by the cartilage and tissue of animals [18,19]. This
carbohydrate diet is a key factor that can (i) modulate the
composition of the gut microbiota [18], (ii) alter bacterial
abundance [12] and (iii) influence nutrient conversion. Indeed,
in the early life of newborns, considerable changes occur in the gut
microbiota when milk is replaced with a plant diet, requiring a
wider range of diverse carbohydrate-active enzymes (CAZymes)
[20,21,22,23]. Though the human genome encodes a tiny number
of CAZymes (at most 17 digestive glycoside hydrolases), which
restricts our own glycan-degrading ability to starch, sucrose and
lactose [21], the human gut microbiota encodes a huge repertoire
of CAZymes [24] that can target and degrade the immense variety
of complex glycans present in our food. After fermentation to
short-chain fatty acids, a fraction of the products from the
breakdown of complex carbohydrates is absorbed by the host,
contributing to approximately 10% of the calories in the human
diet [25,26] and promoting beneficial effects, including laxation,
reduction in blood cholesterol and/or blood glucose levels [27]
and prevention of colorectal cancer [26].
Metagenomic studies based on shotgun sequencing and coupled
to biochemical characterizations have identified several important
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CAZyme families that degrade plant polysaccharides [4,21,25,28],
and these enzymes have been found in the digestive tract of
humans and many animals. In Canterel et al. [21] metagenomic
survey, authors have used the HMP (Human Microbiome Project)
Illumina shotgun metagenomic reads of microbial communities
isolated from five human body sites of 148 subjects to compare the
prevalence and abundance of CAZymes. However, the shotgun
metagenomic sequencing is generally not deep enough [29] and
this could results in underestimation of the real diversity of CAZy
families in a complex communities. For example, cellulases from
the glycoside hydrolase GH6 (For a family classification of
glycoside hydrolases, see reference 20) family appear to be missing
from metagenomic surveys of gut microbiomes, including those of
cows [30,31], wallabies [32], reindeer [33] and dozens of other
mammals [34]. GH6 enzymes are also absent from metagenomic
surveys of the termite hindgut [35] and other herbivore insect
microbiomes [36]. In addition, genes encoding GH6 enzymes
have not been detected in any of the hundreds of human
microbiomes investigated [21,28]. All in all, this systematic
absence suggests that GH6 enzymes can be used as negative
controls in the investigation of carbohydrate-active enzymes from
the distal gut microbiota. In the current study, we designed and
tested a custom microarray as an alternative approach to profile
the CAZymes encoded by the human gut microbiome. The
custom microarray used DNA probes specific for 6,568 genes of
glycoside hydrolases (GHs) and polysaccharide lyases (PLs) to
explore the CAZyme families in the gut microbiome using fecal
DNA samples from subjects with very different diets, including
obese, lean and anorexic individuals.
Materials and Methods
Ethics and sample collection
All aspects of the study were approved by the local ethics
committee, ‘Comite d’e´thique de l9IFR 48, Service de Me´decine
Le´gale’ (Faculte´ de Me´decine, Marseille, France), under the
accession number, 10-002 (January 2010) untitled metagenomic
study of the gut microbiota. Written consent was obtained for all
the patients.
To avoid the possible bias associated with gender, fecal samples
were collected from eight female subjects. Three were obese (BMI
kg m22: 35, 46.8 and 51.3, respectively; age: 42, 21 and 65 years
old, respectively) that were admitted to the Timone Hospital of
Marseille to determine if they were eligible for bariatric surgery.
Three were anorexic women (BMI kg m22: 9.8, 10 and 13.7,
respectively; age: 19, 23 and 49 years old, respectively) that were
admitted to the nutrition department because they suffered from
active restrictive anorexia nervosa complicated by severe under-
nutrition. Stool samples were collected in the first week and were
stored at 280uC. None of these patients were treated with
antibiotics during the month preceding admission. Finally, two
fecal samples, stored at 280uC, from lean women (BMI kg m22:
18.6 and 23.42; age: 21 and 52 years old), were used from a
previous report [37].
DNA extraction and purification
The human fecal bacteria DNA was obtained using phenol-
chloroform extraction based on the protocol adapted by Zoetendal
et al. [38] from the eight fecal samples described above.
Purification of the DNA was performed using a commercial
QIAamp DNA Mini Kit (Qiagen: http://www.qiagen.com/).
DNA quantity was assessed using a NanoDrop ND-1000
spectrophotometer (NanoDrop, Inc.). All purified DNA was stored
at 220uC until use.
Selection of the genes encoding CAZymes
One hundred and seventy-four genomes (finished or high-
quality drafts) of distal gut bacteria were selected from the HMP-
IMG database (http://img.jgi.doe.gov/cgi-bin/imgm_hmp/main.
cgi). This resulted in an overall phylum distribution similar to that
found in the human gut microbiota [24]. Each genome was
searched for its potential CAZyme genes using the family
assignment procedure used for the daily updates of the CAZy
database (www.cazy.org) [20]. A total of 6,855 GHs and 175 PLs
were retrieved by this procedure. The list of selected GH and PL
genes, their CAZy family classification and the corresponding
bacterial reference genome, along with their corresponding phyla,
are reported in Table S1. The DNA sequences of the selected
genes were used for the probe design. Each selected gene sequence
is specific to a given bacterium. Based on this propriety, we
deduced, for each CAZyme gene, the corresponding bacterial
strain and thereby estimated the taxonomical distribution of the
detected CAZyme gene.
Custom microarray design
The design of the custom oligonucleotide microarray was
performed using the Agilent e-array online portal (https://earray.
chem.agilent.com/earray/). The probe design targeted 60-mer
oligonucleotides for the 7,030 selected GH and PL genes. Three
different probes were designed per gene. In addition, the three
probes per gene were spotted in triplicate (see Figure S1). For
each probe, the Agilent probe design algorithm assigned a score
that reflected the hybridization quality based on the base
composition content (BC) methodology [39]. Five grades of BC
scores were defined and indicated the quality of the designed
probes. These different scores were, from the best to the worst,
BC_1, BC_2, BC_3, BC_4 and BC_Poor. Probes with a BC score
of 1 or 2 had a greater chance of forming a stable and consistent
duplex with their targets. Finally, our custom microarray included
1,319 Agilent internal control probes that represented 1) positive
controls that show predictable signal intensities, 2) negative
controls that are designed to show no signal after hybridization
and are used as part of the background subtraction and 3)
manufacturing controls that are used for quality control and to
troubleshoot arrays that do not perform as expected. All the
designed probes were then synthesized in-situ on a glass slide using
Agilent SurePrint technology to obtain a high-density DNA
microarray platform with over 60,000 probes. We used the
8660 k Agilent format to replicate our array design eight times on
the glass slide, with each array containing 62,976 features in total.
Probes were randomly placed on the array to avoid position bias.
The full description of our CAZyme-microarray platform is
publically available online from the GEO database (http://www.
ncbi.nlm.nih.gov/geo/) under the accession number GPL17807.
Biological controls
We used biological positive controls, which included 123 probes
targeting the bacterial 16S rRNA genes of 41 fecal bacteria (three
probes for each gene) and the genes encoding CAZymes belonging
to glycosyltransferase family 28, which are involved in peptido-
glycan synthesis (three different probes for 172 genes encoding
GT28 enzymes). We also used negative controls with 36 probes
targeting 12 human lysozyme genes, 59 synthetic probes (for which
BLASTn against nr database did not provide any hits) and four
genes encoding GH6 cellulases.
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Labeling of target DNA
The genomic DNA ULS (Universal Linkage System) Labeling
KitTM and the ULS-Cy3 (Agilent Technologies) reagent were used
to perform the DNA labeling following the supplier’s instructions
for an 8660K microarray. For the eight samples, the same
amount of DNA (250 ng in a volume of 8 mL of nuclease-free
water) was utilized for the labeling. Before labeling, the extracted
genomic DNA was fragmented by heating at 95uC in a PCR
thermocycler for 10 minutes, followed immediately by a 3-minutes
hold at 4uC. Such a protocol usually results in DNA fragments of
at least 10 KB (see for more details the protocol of ‘‘Agilent
Oligonucleotide Array-Based CGH for Genomic DNA Analysis’’,
version 3.1, August 2009, manual part number G4410-90020).
The fragmented DNA was labeled with a one-color fluorescence
dye (Cyanine 3). A total of 2 mL of Agilent Labeling Master Mix
was added then to 8 mL of DNA fragments. For each reaction, the
Labeling Master Mix contained 0.75, 0.25, and 1 mL of nuclease-
free water, ULS-Cy3 and 106 labeling solution, respectively. The
eight reaction mixtures were incubated at 85uC for 30 minutes and
then transferred immediately on ice for 3 minutes. The removal of
non-reacted ULS-Cyanine 3 was performed using Agilent
KREApure columns (the Genomic DNA Purification Module).
The efficiency of the DNA labeling was measured using a
NanoDrop ND-1000 spectrophotometer to determine the absor-
bance at A260 nm for the labeled DNA and at A550 nm for Cy3
dye. The degree of labeling was thus calculated as indicated by
the manufacturing protocol as follow:
Degree of Labeling ~
340 x pmol per mL dye
ng per mL genomic DNA x 100
x 100:
Microarray hybridization
After removing the non-reacted dye, 9 ml of each labeled DNA
sample was mixed with 25 mL of the hybridization master mix that
corresponded to Agilent 86 microarray format. For each DNA
sample, an amount of 250 ng was used for hybridization with a
degree of Cy-3 labeling that varied from 1.64% to 3.1%
throughout the eight samples which indicated an optimal degree
of labeling as described in the manufacturing protocol (range of
optimal degree of Cy-3 labeling is between 1.75% and 3.5%). The
hybridization master mix was prepared with 0.5 ml of Agilent
1006 CGH Blocking Agent and 24.5 ml of Agilent 26 CGH
Hybridization Buffer per hybridization (8 samples). The final
volume for each hybridization mixture was 34 ml after adding the
Agilent CGH Blocking Agent to the labeled DNA. The
hybridization mixture was applied directly to the gasket slide,
and the active side of the microarray slide was placed on top of the
gasket to form a ‘‘sandwich slide pair’’. The microarray slide was
placed immediately in a hybridization oven set to 65uC for 46
hours with a rotation of 20 rpm as recommended by the
manufacturer. To clean the microarray after hybridization, a
series of washes was performed using Oligo aCGH Wash Buffer 1
and Oligo aCGH Wash Buffer 2 (Agilent Technologies).
Microarray scanning and data processing
After hybridization and cleaning, the arrays were immediately
scanned using an Agilent Microarray Scanner with Agilent
Scanner Control software v7.0 and a resolution of 3 mm. The
scanned images were analyzed by quantifying the pixel density
(intensity) of each spot using the Agilent Feature Extraction (AFE)
software v9.5. The mean signal was determined for each spot of
the eight hybridized arrays. The local median background signals
were subtracted from the mean spot intensity using the ‘‘back-
groundCorrect’’ function and ‘‘half’’ method implemented in the
‘limma’ package available from the Bioconductor website (http://
www.bioconductor.org/).The signal values of all spots were then
normalized between the arrays using the ‘‘limma’’ function
‘‘normalizeBetweenArrays’’ and the ‘‘quantile’’ method [40].
We used AFE to assess all spots (probes) and determine errors in
signal quantification, and non-uniform features. To identify the
significant signals or successful hybridizations, many criteria were
taken into account. The feature mean signal had to be
distinguishable from the local background signal. To do so, the
two-sided Student’s t-test had to be significant, and the
background-corrected mean signal had to be greater than 2.6
times the standard deviation (SD) of the local background. Because
the degree of freedom was large enough, the pixel intensities were
believed to vary following a normal distribution. Therefore, an
additive error model was used to measure the significance of
signals. In the fact, the background signal distribution was
assumed to be approximately 0 with one error, which was defined
as one standard deviation (1 SD) from the probability of 0 and
equal to a p-value of 0.01. Thus, to ensure that the pixels of
interest were contained within the rejection boundaries of a 99%
confidence interval (p-value#0.01), the corrected mean signal of
the corresponding feature had to be greater than 2.6 times the SD
background (for more details on the statistical models, see the AFE
reference guide at URL: http://www.chem.agilent.com/Library/
usermanuals/Public/ReferenceGuide_050416.pdf).
In addition, the probe mean signal had to be significantly
different from the mean of the negative controls (. mean negative
control + 1.56 the standard deviation of the negative controls).
Accordingly, the following probes were filtered out: (1) the control
probes, (2) the probes with a signal that was not significant above
background, (3) the probes with a signal that was not higher than
the controls and finally, (4) the probes with non-uniform outliers (if
the pixel noise of the corresponding feature exceeded a threshold
established for uniformity based on statistical deviation from the
expected noise).
GH6-specific polymerase chain reaction
We used the NCBI primer design tool (Primer-Blast) to design
specific primers to amplify the gene encoding the GH6 enzyme of
Brachybacterium faecium (NCBI accession number ACU85160) from
our fecal DNA samples. Forward (59-
GCTTCTCGCTCAACGTCTCGAACT-39) and reverse (59-
AGCAGGAGCTCCGCGTCCTC-39) primers were used to
amplify a 220-bp amplicon of the gene. As a positive control,
genomic DNA was extracted from the standard strain, Brachy-
bacterium faecium, which contains the GH6 enzyme gene used in
microarray design.
Each PCR contained 2.5 ml of 106PCR Buffer (Qiagen), 2.5 ml
of dNTPs (final concentration of 200 mM for each dNTP), 1.2 ml
of MgCl2 (1.5 mM), 1 ml of Taq DNA polymerase (Invitrogene),
0.5 ml of each primer and 0.5 ml of DNA (with a concentration of
20 ng/ml). The final volume was adjusted to 25 ml by adding sterile
ultrapure water. The PCR conditions consisted of an initial
denaturation step at 95uC for 5 minutes, followed by 35 cycles of
95uC for 30 seconds, 62uC for 15 seconds and 72uC for 2 minutes.
A final extension of 10 minutes at 72uC was then performed. The
PCR products were separated by electrophoresis using 2% agarose
gels containing 0.5 mg/ml of ethidium bromide and visualized
using a UV transilluminator.
Exploring the CAZyme Genes of the Gut Microbiome
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Sequencing of the amplification products
The sequencing reaction was performed using the BigDye
Terminator Cycle Sequencing Ready Reaction kit (Catalog
Number 4337458). The cycle reaction was performed by adding
4 mL of the purified primary PCR product to a mix containing
4 ml of BigDye Terminator v1.1, 4 mL of 56buffer and 0.5 mL of
each of the forward or reverse primers used previously for the
amplification. The final volume was adjusted to 15 mL by adding
sterile ultrapure water. The PCR conditions included a denatur-
ation step at 96uC for 3 minutes, followed by 26 cycles of
denaturation at 96uC for 30 seconds, annealing at 55uC for 15
seconds and an extension at 60uC for 4 minutes. After gel filtration
using Sephadex G-50, the PCR products were run on an ABI
3100 Genetic Analyzer to obtain the corresponding sequences.
The resulting sequences were corrected and assembled using the
ChromasPro 1.4.2 tool. The assembled sequences were analyzed
by alignment with sequences in the ‘‘non-redundant’’ GenBank
database.
Results
Microarray validation
We have established a dataset of 7,030 genes encoding GHs and
PLs for the design of custom microarray platform. Probe design
was positive for 6,564 gene targets representing 93% of the initially
selected CAZyme genes from 174 reference genomes (Table S1
and Table S2). The description of the microarray platform and
the corresponding data have been deposited on the online
database GEO (http://www.ncbi.nlm.nih.gov/geo/) and are
publically available under the accession number GPL17807.
The near identical gene sequences (over 95% identity and over
95% coverage) in our dataset were removed to ensure the design of
unique probes and to avoid cross-hybridization events. Thus, for
all targets, high-quality probes that do not cross-hybridize to other
sequences were selected to construct the microarray. For the
successful target candidates, three different probes were designed,
resulting in a set of 19,692 unique probes of 60-mers (Table S2).
The majority of these probes (81.7%) had the highest quality score
(BC1), whereas 15% of the probes had a score of BC2. Only a
small fraction of the probes were scored as BC3 (1.2%), BC4
(0.8%) and BC_Poor (1.3%).
Using the e-array platform, the quality of the designed probes
was further assessed by estimating the potential targets and cross-
hybridization problems if sequences other than target hybridized
to a probe. For all our designed probes, the potential score for
cross-hybridization events was 0. Thus, only the target sequence is
believed to form a duplex with the corresponding probe on the
arrays.
In addition to the CAZymes probes, our microarray featured a
number of probes that were replicated up to ten times and spotted
randomly across the array to evaluate the reproducibility of the
platform by calculating the percent of the coefficient of variation
(%CV) for each one of the eight arrays. We used the R function
‘‘CV.rep.probes’’ of the package ‘‘Agi4644PreProcess’’ to identify
the sets of replicated probes and calculate the corresponding %CV
for every probe set. The median value of %CVs within each array
was considered as the CV of this array. A lower CV median
indicates a better array reproducibility of signal intensity and
hybridization uniformity. The median %CV of all the arrays
tested was less than 2%, indicating good reproducibility of the
array (Figure S2). The mean value of the melting temperature
(Tm) of the designed probes was 83.6uC, with a standard deviation
of 1.64uC, and the mean value of the GC content was 43.75% (see
Table S2 for details of all the probes).
Significance of hybridization
Genomic bacterial DNA was extracted from eight different stool
samples and hybridized against the designed probes on the glass
slide (8 arrays). We considered that hybridization between the
probe and the corresponding target was successful if it responded
to the criteria and statistics described above. Thus, the hybridiza-
tion of 28,690 probes out of 59,079 was significant in at least one
array. Each gene target was represented by three different probes,
which were replicated three times on the microarray (nine probes
for one gene). Thus, a given gene was considered present in the
sample if at least six of the corresponding probes (out of nine) had
a significant hybridization (Figure S1). The gene was judged
absent if, however, at most three of the corresponding probes were
positive. We established thus a Presence-Absence matrix (Table
S3) for all genes and samples studied following the conditions
described above.
Analysis of detected CAZyme genes
The CAZyme microarray platform was assessed on fecal
samples isolated from eight women with wide variations in their
BMI (ranging from 9.8 to 51.3 kg m22). Conclusions from the
different health states (3 anorexic, 2 lean and 3 obese individuals)
were not possible because of the small number of samples in each
group. However, the full sample (8 female individuals) allowed us
to report some general tendencies. Among the 6,564 spotted
CAZyme genes (Table S2), 3.3% were absent, and 5% were
present in all tested samples. For 11.4% of the genes, the detection
was deemed ambiguous according to our analysis criteria (Table
S3). At the group level, we detected, on average, more CAZyme
genes in the anorexic group (1,901 genes) than in the lean (1,765
genes) or obese (1,391 genes) groups (Figure 1). However, no
significant difference was found between the groups. At the
individual level, an important variability was observed in the
detected CAZyme genes for both obese and anorexic individuals,
whereas the lean individuals displayed limited variability,
presumably because of the fewer number of tested samples (there
were only two lean subjects) (Figure 1 and Figure 2).
Figure 1. Boxplots of detected CAZyme genes among sample
groups. Each box plot diagram indicates the variation of the number
of detected genes within sample groups (lean, anorexic and obese). The
horizontal black lines inside the box plots indicate the mean number of
detected CAZyme gene within the group sample. The horizontal green
line indicates the overall mean of detected genes in the eight samples.
doi:10.1371/journal.pone.0084033.g001
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Further, we defined the core CAZyme genes for a given group
as the number of detected CAZyme genes that were shared among
all the individuals of the group (Venn diagrams in Figure 2). The
core CAZyme genes of the anorexic and the obese groups included
669 and 544 genes, respectively. In addition, the phylum
taxonomic classification deduced from the core CAZyme genes
in the obese, anorexic and lean groups indicated a higher
proportion of Actinobacteria in the obese core (45%) than in the
lean (21%) and anorexic (23%) cores (Figure 2). Proteobacteria
was the predominant phylum in the anorexic core (33%) but was
less represented in the obese core (7%). Overall, the phyla
distributions were somewhat similar between the lean and
anorexic core CAZyme genes, whereas those of the obese core
exhibited greater differences (Figure 2). Although the phylum
taxonomic distribution of the three CAZyme cores was variable,
the diversity and proportion of the CAZyme families between the
three cores displayed a conservation tendency. Indeed, the
diversity of the CAZyme families was similar for the anorexic
(57 families) and obese (62 families) cores. The larger number of
CAZyme families found in the lean core (79 families) presumably
resulted from the lower number of tested subjects. Finally, all of
the CAZyme families identified for the anorexic and obese cores
were shared with those of the lean core and cover a large range of
GH and PL families that allow breakdown of a large variety of
CAZyme substrates.
Identification of a microarray-based core CAZome
Next, we examined the detected and shared CAZyme genes
among the eight samples independently of the corresponding
health state. The core CAZome was defined as the number of
detected CAZyme genes shared by the eight tested individuals.
Accordingly, the core CAZome of our sampling consists of 318
GHs and PLs (out of 6,564 selected genes). The phylum
distribution (Figure 3) deduced from this core CAZome indicated
the predominance of the Actinobacteria (35%) and Firmicutes
(34%) phyla, along with Bacteroidetes (9%), Proteobacteria (10%),
Verucomicrobia (2%) and the unusual Lentisphaerae (10%).
Importantly, the CAZyme family classification (Figure 3) of the
detected genes of the core CAZome preserved considerable
diversity, with 46 CAZyme families detected, that acts on a large
Figure 2. Comparison of detected CAZyme genes between and within samples. The numbers of unique and shared CAZyme genes
between samples are represented as a Venn diagram. The phylum distribution of the core CAZyme genes of each group are shown in different colors
(blue, Firmicutes; red, Bacteroidetes; yellow, Actinobacteria; purple, Proteobacteria; olive green, Lentisphaerae; brown, Verrucomicrobia). The CAZyme
family composition of the cores is shown in rainbow colors.
doi:10.1371/journal.pone.0084033.g002
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variety of carbohydrate substrates provided by the diet, including
starch and glycogen (GH13), the plant cell wall (GH3, GH31,
GH36 and GH43) and animal glycans (GH20). For a survey of the
substrates of the GH families, see reference [24].
A GH6-encoding gene detected in the human gut
Enzymes of the GH6 family target and break down cellulose,
the major component of the plant cell wall. However, a systematic
absence of these GH6 enzymes has been observed in published
metagenomic studies of the human or herbivore animal gut.
Therefore, we spotted four genes encoding enzymes belonging to
the GH6 family as negative controls on the microarray. To our
surprise, one of these genes was detected in all eight members of
the study cohort. For each sample, the detection sensitivity varied
from seven to nine positive probes over 9 spotted probes. The
detected GH6-encoding gene corresponded to a cellobiohydrolase
gene with GenBank accession number ACU85160. The presence
of this enzyme was verified and positively confirmed by PCR using
specific gene primers (Figure 4). The PCR products from the
eight samples were then sequenced and analyzed for sequence
similarity using Blast and the non-redundant GenBank database.
The best Blast hit for all the PCR products as well as the positive
control was a gene from Brachybacterium faecium DSM 4810, which
shared at least 99% sequence identity with the target region of the
cellobiohydrolase in the samples (Table 1). The second (and final)
Blast hit partially matched a gene encoding a putative endo-1,4-b-
glucanase of Streptomyces avermitilis MA-4680, which also belongs to
the GH6 family.
Discussion
The purpose of this work was to develop an integrated
microarray platform for the profiling of the CAZyme gene
repertory of the human distal gut microbiota. From 174 public
reference genomes, we first retained 6,564 non-redundant
CAZyme genes (6,393 GHs and 175 PLs) using the CAZyme
annotation gene pipeline [20] and the Agilent eArray tool, which
removes gene redundancy. To increase the stringency of positive
gene detection, three probes per gene were designed using the
Agilent eArray tool, and each probe was spotted in triplicate. To
be considered detected or present, a gene required the detection of
at least two of the three probes, and a probe signal was considered
positive if present in at least two of the triplicated spots (Figure
S1). This allowed us to examine, with high relevance and
stringency, the presence of CAZyme genes in the tested fecal
DNA samples of eight women where each gene was targeted by
nine probes, and this gene was considered present only if six out of
its nine corresponding probes had a significant hybridization. In
addition, 96.2% of the designed probes had a very good BC score
(81.2% of the probes BC1 and 15% had a score BC2), highlighting
the high quality of the microarray platform. Furthermore, the
calculation of the coefficient of variation within each array using
the replicated probe sets displayed a low %CV, indicating a good
hybridization reproducibility of the arrays.
Figure 3. CAZy family content and the associated phyla classification of the core CAZome. A total of 318 CAZyme genes were commonly
detected in the eight samples and composed the core CAZome. The proportions of corresponding CAZy families are shown in rainbow colors. The
phylum distribution of the core CAZyme genes within each group are shown in different colors (blue, Firmicutes; red, Bacteroidetes; yellow,
Actinobacteria; purple, Proteobacteria; olive green, Lentisphaerae; brown, Verrucomicrobia).
doi:10.1371/journal.pone.0084033.g003
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The microarray analysis revealed an important variability of the
CAZyme profile between female individuals at the gene level.
However, the variability of the CAZyme profiles decreased
dramatically at the family level (Figure 2), as the diversity and
proportion of different GH and PL families were found to be in the
same range for the anorexic, obese and lean core profiles. This
finding is in agreement with previous reports on the human
microbiota, in which similar groups of functional genes were found
despite the highly divergent composition of microbiota between
individuals [28,41,42]. In addition, the core CAZome contained
GH and PL families, which allow the degradation of a wide variety
of plant and animal polysaccharides (Figure 3). Therefore, we
conclude that the changes in the composition of the microbiota
that are associated with the physiological states examined in this
short cohort do not appear to be accompanied by important
alterations in the functional capabilities of the enzymes despite
wide differences in the BMIs of the tested women. The
redundancy of the genes encoding CAZymes in fecal bacteria
could be crucial to maintaining metabolic abilities when the
bacterial composition of the gut changes.
Cellulose, which is found in plant cell walls along with
hemicellulose and pectin, is a dietary fiber that is present in fruits
and vegetables. The breakdown of cellulose components by
bacteria is ensured by "reducing end-acting" cellobiohydrolases of
the GH48 family, which are believed to act in a synergistic manner
with "non-reducing" end acting cellobiohydrolases of the GH6
family and endo-acting cellulases [43]. However, GH6 enzymes
have not been identified in any human or animal gut microbiome
[21,28,30,31,32,33,34] until the current study, even though
cellobiohydrolases are believed to be essential cellulases because
they produce soluble cellobiose from cellulose in a single step [43].
Contrary to metagenomic studies, our findings revealed the
presence of genes belonging to the GH6 family in our eight
samples. This result suggests that our microarray approach is able
to reveal low-abundance genes that may be missed by metage-
nomic studies because such studies exhibit sequencing depth bias,
especially for low-abundance species. Obviously, the inability to
detect GH6 enzymes in the metagenomic studies of the animal
and human gut does not imply their absence. Accordingly, our
study confirmed the limitation reported recently [21] of the ability
of metagenomic methods, based on Illumina shotgun reads, to
identify the CAZyme profile of the human gut from taxonomic
profiling because of possible differences in gene content between
bacteria of the same genus, species or strain that cannot be
detected by 16S rRNA [21]. The relevance of the predicted
CAZome is therefore dependent on the way the taxonomic groups
are covered by the reference genomes, resulting in the overesti-
mation of CAZyme families from the abundant bacteria and an
underestimation of genes belonging to less abundant bacterial
groups [21].
We conclude that microarray and metagenomic analyses are
complementary methods for investigating the carbohydrate-active
enzyme profiles of the gut microbiota. The microarray is
important for the detection of CAZyme genes present in low-
abundance species and thus provides a higher resolution of the
enzymatic diversity in a complex ecosystem such as the
microbiota. The 16S RNA gene-sequencing approach is still
important for determining the global taxonomical composition of
the human microbiota despite its limitation in identifying low-
abundance bacterial groups. As the number of reference genomes
Figure 4. Agarose gel electrophoresis of the PCR products. The PCR products correspond to the amplification of 220 bp target region of the
GH6 cellulase gene from the obese (wells S1, S2 and S3), anorexic (wells S4, S5 and S6) and lean (wells S7 and S8) samples. The well ‘‘M’’ indicates the
molecular weight size markers and ‘‘C’’ is the positive control and corresponds to the amplification product of the GH6 gene of interest from the
Brachybacterium faecium DSM 4810.
doi:10.1371/journal.pone.0084033.g004
Table 1. BLAST results of sequenced PCR products against NCBI nr database.
BLAST hits 1,4-b-cellobiosidase A (ACU85160) putative endo-1,4-b-glucanase (BA000030)
Samples Identity (%) Coverage (%) Identity (%) Coverage (%)
Obese 1 99 91.4 97 15
Obese 2 100 100 97 15
Obese 3 99 99.5 97 15
Anorexic 1 100 100 97 15
Anorexic 2 99 99.5 97 15
Anorexic 3 100 100 97 15
Lean 1 100 100 97 15
Lean 2 99 99.5 97 15
Control + 100 100 97 15
doi:10.1371/journal.pone.0084033.t001
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continues to increase, we believe that future CAZyme microarrays
will be able to capture a larger portion of the CAZome of an
individual.
Supporting Information
Table S1 The list of all CAZyme genes selected from 174
bacterial reference genomes associated to the human
gastrointestinal tract.
(XLSX)
Table S2 The list of all probes spotted on the custom
microarray and the corresponding characteristics.
(XLSX)
Table S3 The presence-absence matrix of all tested
CAZyme genes among samples. The presence and the
absence of each gene are indicated in the corresponding sample by
‘‘1’’ and ‘‘21’’, respectively. The value of ‘‘0’’ is given when the
presence of a given gene remains ambiguous.
(XLSX)
Figure S1 Steps for probe design and threshold for gene
detection. A minimum of six out of nine positive signals,
corresponding to a minimum of two positive probes over three, is
required to consider a gene as detected. A minimum of five out of
nine positive signals will allow the case to have only one positive
probe over three, which is not acceptable. The green and red spots
indicate positive and negative signals, respectively. Two significant
signals for a given probe show that the probe is positive (+). Two
positive probes indicate that the gene is detected.
(TIF)
Figure S2 Boxplots of the %CV values (coefficient of
variation) of replicated probes on each microarray. The
X-axis represents the individual microarray experiment:61 to63
indicate samples from obese 1, obese 2 and obese 3 subjects;64 to
66 correspond to anorexic 1, anorexic 2 and anorexic 3;67 and
68 represent samples from lean 1 and lean 2 subjects.
(TIF)
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